A generic drug company's unusual approach to fending off Sunovion's patent infringement claims won the blessing of a trial judge. But it met its demise at the U.S. Court of Appeals for the Federal Circuit on Thursday.
Paul Hastings Scores for Sunovion in Lunesta Patent Fight
The Litigation Daily
September 26, 2013